FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

35642611000001108: Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Aug 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
109423301000001110 Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
109423401000001119 Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets Is a Bictegravir + Emtricitabine + Tenofovir alafenamide true Inferred relationship Existential restriction modifier
Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets Has specific active ingredient Bictegravir false Inferred relationship Existential restriction modifier
Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets Has specific active ingredient Emtricitabine true Inferred relationship Existential restriction modifier
Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets Has specific active ingredient Tenofovir alafenamide fumarate true Inferred relationship Existential restriction modifier
Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tenofovir alafenamide true Inferred relationship Existential restriction modifier
Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets Has active ingredient Emtricitabine true Inferred relationship Existential restriction modifier
Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets Has active ingredient Tenofovir true Inferred relationship Existential restriction modifier
Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets Has active ingredient Substance with integrase strand transfer inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets Has specific active ingredient Bictegravir true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Biktarvy 50mg/200mg/25mg tablets (Gilead Sciences Ltd) Is a True Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets Inferred relationship Existential restriction modifier
Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets 30 tablet Has VMP True Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start